Ceres and Denso partnership investor meeting today
Source: RNS6 August 2024
Ceres Power Holdings plc
("Ceres", the "Company")
Ceres and Denso partnership investor meeting today
Ceres Power Holdings plc ("Ceres", the "Company"), a leading developer of clean energy technology, will hold a call for investors on 6 August 2024 at 10.30 BST in relation to the signing of a collaboration with Denso Corporation ("Denso"), confirmed as the Company's recent licence partner this morning.
The presentation will be hosted by Phil Caldwell, Chief Executive Officer, and Eric Lakin, Chief Financial Officer of Ceres.
To register to participate, please go to: https://www.investormeetcompany.com/ceres-power-holdings-plc/register-investor.
Ends
For further information visit www.ceres.tech or contact:
Ceres Power Holdings plc Patrick Yau/ Merryl Black |
|
Tel: +44 (0)7884 654179 Email: investors@cerespower.com |
FTI Consulting (Financial PR) Dwight Burden / Ben Brewerton
|
|
Tel: +44 (0)203 727 1000 Email: ceres_power@fticonsulting.com
|
About Ceres
Ceres is a leading developer of clean energy technology: electrolysis for the production of green hydrogen and fuel cells for power generation. Its asset-light, licensing model has seen it establish partnerships with some of the world's largest companies, such as Bosch, Doosan, Delta, Denso and Weichai. Ceres' solid oxide technology supports greater electrification of our energy systems and produces green hydrogen at high-efficiencies as a route to decarbonise emissions-intensive industries such as steelmaking, ammonia and future fuels. Ceres is listed on the London Stock Exchange ("LSE") (LSE: CWR) and is classified by the LSE Green Economy Mark, which recognises listed companies that derive more than 50% of their activity from the green economy. Read more on our website www.ceres.tech or follow us on LinkedIn.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.